Royal Bank of Canada
TRAW icon

Royal Bank of Canada’s Traws Pharma TRAW Stock Holding History

Royal Bank of Canada’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Buy
+6
New +$11 ﹤0.01% 7792
2024
Q3 		– Sell
-5
Closed – – 7574
2024
Q2 		$0 Hold
5
– – ﹤0.01% 7628
2024
Q1 		$0 Sell
5
-11
-69% -$212 ﹤0.01% 7700
2023
Q4 		$0 Buy
16
+8
+100% +$136 ﹤0.01% 7666
2023
Q3 		$0 Buy
8
+6
+300% +$137 ﹤0.01% 7693
2023
Q2 		$0 Hold
2
– – ﹤0.01% 7727
2023
Q1 		$0 Hold
2
– – ﹤0.01% 7572
2022
Q4 		$0 Sell
2
-2
-50% -$38 ﹤0.01% 7810
2022
Q3 		$0 Hold
4
– – ﹤0.01% 7951
2022
Q2 		$0 Hold
4
– – ﹤0.01% 7783
2022
Q1 		$0 Hold
4
– – ﹤0.01% 8083
2021
Q4 		$0 Hold
4
– – ﹤0.01% 7945
2021
Q3 		$0 Buy
+4
New +$515 ﹤0.01% 7918
2020
Q3 		– Sell
-1
Closed – – 6981
2020
Q2 		$0 Hold
1
– – ﹤0.01% 6956
2020
Q1 		$0 Hold
1
– – ﹤0.01% 7093
2019
Q4 		$0 Buy
+1
New +$187 ﹤0.01% 7180
2018
Q4 		– Hold
0
– – – 7172
2018
Q3 		– Hold
0
– – – 6987
2018
Q2 		– Hold
0
– – – 6813
2018
Q1 		– Hold
0
– – – 6857
2017
Q4 		– Hold
0
– – – 6948
2017
Q3 		– Hold
0
– – – 7028
2017
Q2 		– Hold
0
– – – 6804
2017
Q1 		– Hold
0
– – – 6854
2016
Q4 		– Hold
0
– – – 6810
2016
Q3 		– Sell
-5
Closed -$102K – 6605
2016
Q2 		$170K Buy
5
+4
+400% +$112K ﹤0.01% 4512
2016
Q1 		$17K Hold
1
– – ﹤0.01% 5558
2015
Q4 		$47K Hold
1
– – ﹤0.01% 5335
2015
Q3 		$67K Hold
1
– – ﹤0.01% 4995
2015
Q2 		$118K Hold
1
– – ﹤0.01% 4725
2015
Q1 		$120K Hold
1
– – ﹤0.01% 4524
2014
Q4 		$108K Hold
1
– – ﹤0.01% 4698
2014
Q3 		$140K Buy
+1
New +$285K ﹤0.01% 4425
2014
Q2 		– Hold
0
– – – 5237
2014
Q1 		– Hold
0
– – – 4945
2013
Q4 		– Hold
0
– -$4K – 6178
2013
Q3 		– Hold
0
– – – 5697

Other funds holding TRAW

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PWM
Palumbo Wealth Management Great Neck, New York $410M AUM 32.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royal Bank of Canada's TRAW Position: Q1 2026 in Review

Royal Bank of Canada opened a new position in Traws Pharma (TRAW) in Q1 2026: 6 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #7792 among its holdings. This is a return to the name: Royal Bank of Canada previously reported a position in TRAW as recently as Q2 2024.

Royal Bank of Canada first reported a position in TRAW in Q3 2014 and has held it in 24 quarters since. The position peaked at $170K in Q2 2016. 28 funds tracked by Wall St. Rank hold TRAW as of Q1 2026.

  • Royal Bank of Canada held 6 shares of Traws Pharma worth $0 as of Q1 2026.
  • Traws Pharma was a new Royal Bank of Canada position in Q1 2026.
  • Traws Pharma made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7792 holding.
  • Royal Bank of Canada first reported a position in Traws Pharma in Q3 2014 and has held it in 24 quarters since.
  • Royal Bank of Canada's Traws Pharma position peaked at $170K in Q2 2016.
  • 28 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.